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Abstract Although an increasing number of in vitro
studies are being published regarding the cytotoxicity
of nanomaterials, the components of the media for
toxicity assays have often varied according to the
needs of the scientists. Our aim for this study was to
evaluate the influence of serum—in this case, fetal
bovine serum—in a cell culture medium on the
toxicity of nano-sized (50–70 nm) and micro-sized
(\1 lm) ZnO on human lung epithelial cells (A549).
The nano- and micro-sized ZnO both exhibited their
highest toxicity when exposed to serum-free media, in
contrast to exposure in media containing 5 or 10 %
serum. This mainly comes not only from the fact that
ZnO particles in the serum-free media have a higher
dosage-per-cell ratio, which results from large aggre-
gates of particles, rapid sedimentation, absence of
protein protection, and lower cell growth rate, but also
that extracellular Zn2? release contributes to cytotox-
icity. Although more extracellular Zn2? release was
observed in serum-containing media, it did not
contribute to nano-ZnO cytotoxicity. Furthermore,
non-dissolved particles underwent size-dependent
particle agglomeration, resulting in size-dependent
toxicity in both serum-containing and serum-free
media. A low correlation between cytotoxicity and
inflammation endpoints in the serum-free medium
suggested that some signaling pathways were changed
or induced. Since cell growth, transcription behavior
for protein production, and physicochemical proper-
ties of ZnO particles all were altered in serum-free
media, we recommend the use of a serum-containing
medium when evaluating the cytotoxicity of NPs.
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Introduction
As new nanomaterials are increasingly synthesized
and applied in consumer products, occupational
workers and end-product users are more likely to
become exposed to potentially harmful effects of these
substances. However, progress in the risk and health
assessment of these new materials lags. In recent
years, researchers have begun to investigate the
adverse effects of nanoparticles (NPs) and their
mechanisms (Oberdorster et al. 2005; Casals et al.
2008; Xia et al. 2008; Hsiao and Huang 2011a, c).
Among all nano-safety issues, the effect of
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physicochemical properties of NPs on biological
responses is widely studied (Rivera Gil et al. 2010;
Shvedova et al. 2010; Hsiao and Huang 2011a).
However, optimal exposure conditions, such as expo-
sure duration for biological in vitro and in vivo studies
has not been standardized, nor has an NP dispersion
guide been proposed. This situation has led to some
arguments over how to determine the effects of the
physicochemical characteristics (e.g., size, shape,
surface area, and surface chemistry) of NPs on their
biological responses (Murdock et al. 2008).
When discussing experimental conditions for in vitro
studies, the distinction between using serum-containing
or serum-free media for biological assays is one of
important issues (Jones and Grainger 2009). Although
many studies have used serum-containing media for
NP-exposure studies (Karlsson et al. 2008, 2009;
Vamanu et al. 2008; Choi et al. 2009), others have used
serum-free media without explaining why they chose to
avoid serum (Brown et al. 2007; Chen et al. 2008;
Braydich-Stolle et al. 2009; Yuan et al. 2010). Further-
more, the amount of serum used in cytotoxicity studies
sometimes differs in studies of the same cell line—with
5 or 10 % serum commonly used in the medium.
Serum, which contains essential proteins and
nutrients for the in vitro system, is commonly used
as a supplement in cell culture media. Serum can also
be a stabilizing agent for NPs (Murdock et al. 2008;
Allouni et al. 2009; Cronholm et al. 2011). In view of
the potential discrepancies, a few groups have begun
to evaluate the effects of serum on particle toxicity
from the aspect of particle agglomeration and surface
chemistry (Davoren et al. 2007; Murdock et al. 2008;
Zhu et al. 2009). For example, the presence of protein-
containing serum in a medium has a protective effect
on the toxicity of both silica and single-walled carbon
nanotubes (Schimmelpfeng et al. 1992; Davoren et al.
2007). Recently, studies have found that the protective
effect on NP toxicity was derived from the binding of
multiple layers of serum proteins (e.g., bovine fibri-
nogenon, gamma globulin, etc.) on NPs to protect cells
from direct interaction (Ge et al. 2011). These ‘‘protein
corona’’ not only change cellular responses, but also
determine kinetics and distribution of NPs in vivo
(Walkey and Chan 2012). Different kinds of protein
corona adsorbed onto silica NPs in the presence or
absence of serum, and even altered adhesion of
particles to the cell surface, affect uptake, toxicity,
and particle localization (Lesniak et al. 2012).
Nano-ZnO has become an attractive nanomaterial
for use in photochemical and biological fields (Yang
and Chan 2009; Kumar and Chen 2008). Many studies
have demonstrated, however, that nano-ZnO has
higher cytotoxicity than those of other metal oxide
or carbon-based NPs (Lin et al. 2009; Yang et al.
2009). Nano-ZnO also induces toxicity in various
mammalian cells (human BEAS-2B, A431, A549 and
mouse C17.2), leading to potent DNA damage,
inflammation, and even cell apoptosis (Huang et al.
2010; Deng et al. 2009; Sharma et al. 2009; Lin et al.
2009). Due to its high toxicity, some studies also
dedicated to remedy it by iron doping or TiO2 coating
(Xia et al. 2011; Hsiao and Huang 2011c). The
cytotoxicity of nano-ZnO appears to be associated
with the release of zinc ions (Zn2?), suggesting the
absence of size-dependent toxicity as the dosage falls
lower than 18.2 lg/mL (Xia et al. 2008; Deng et al.
2009); nevertheless, some studies indicate particle–
cell contact which induces reactive oxygen species,
leading to cytotoxicity (Yang et al. 2009; Moos et al.
2010). In the absence of serum, nano-ZnO exposed to
A549 cells caused a significant decrease in the
cytokinesis-block proliferation index (CBPI) at
25 lg/mL, while in the presence of 10 % serum the
same result showed at only 50 lg/mL (Corradi et al.
2012). The nano-bio-complex, with selective bindings
of components or ions of medium to nano-ZnO, could
be observed in Dulbecco’s modified Eagle’s medium
(DMEM) w/wo serum and phosphate-buffered saline
(PBS). The bindings were found to be independent of
serum proteins (Xu et al. 2012). In summary, the
complexity of serum on the sample characters, solu-
tion properties and toxicity of ZnO particles have not
been well understood.
In this study, we investigated the influence of serum
in the DMEM medium on the toxicity of nano- and
micro-sized ZnO toward human lung epithelial cells.
We wanted to understand and explain: (1) if there are
any differences in the results of cytotoxicity on
different sizes of ZnO particles, (2) what is the extent
of extracellular Zn2? released from ZnO suspension
and its role on the cytotoxicity and, (3) if the
correlation of endpoints (cytotoxicity and inflamma-
tion) changes in various serum conditions. We discuss
our biological response data (mitochondria activities
and production of pro-inflammatory factor IL-8) under
different exposure conditions of ZnO particles by
varying the size distribution, hydrodynamic size,
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sedimentation states, and zinc ion release. Herein,




Nano-sized (50–70 nm) and micro-sized (\1 lm)
ZnO commercial powders were purchased, respec-
tively, from Sigma-Aldrich Corp. (St. Louis, MO,
USA) and Sun Beam Tech (Taiwan). All aqueous
solutions used in the chemical and biological exper-
iments were prepared from 18.2 MX cm ultrapure de-
ionized and sterilized water, obtained from Millipore
Simplicity Systems (Millipore, S.A.S.).
Size and surface area analysis
The particle sizes and morphologies of the commercial
powder were analyzed using a TECNAI 20 transmis-
sion electron microscope (Philips, Netherlands). To
prepare the samples, NPs were first dispersed in
absolute ethanol (100 lg/mL) and then sonicated
(400 W, 40 kHz) for 30 min. Aliquots (4 lL) of the
suspensions were deposited onto 200-mesh carbon-
formvar Cu grids. Finally, the solvents were evapo-
rated in a vacuum oven for 1 h. The surface area of
ZnO particles was determined by N2 adsorption–
desorption isotherms obtained at 77 K using ASAP
2020 Micromeritics Surface Area and Porosity Ana-
lyzer. Surface area was calculated by the Brunauer–
Emmett–Teller (BET) method.
Size distribution measurements in air and medium
system
To determine the real-size distributions of the ZnO
particles, an electrical low-pressure impactor (ELPI,
Dekati, Finland) was used to monitor the size distri-
bution of the particles in air. The ELPI could measure
the airborne particle size distribution in the size range
of 0.03–10 lm with 12 channels. First, an amount of
powder (after storage in a drying box for 1 week) was
placed in a self-made chamber (length 0.5 m; width
0.4 m; height 0.5 m). Using a blower (1.2 m3/min),
the particles were agitated for 30 min and collected by
the ELPI. The alumina foils in each channel sensed the
charged particles and a program calculated its number
distribution. The temperature during measurement
was 16.3 C; the relative humidity was 75 %.
The hydrodynamic size and surface charge of the
ZnO particles in water and the cell culture medium
were monitored using a Zetasizer Nano ZS apparatus
(Malvern Instruments, UK). The hydrodynamic size of
the particles is expressed herein as the Z-average size,
which was derived from the cumulant mean of the
intensity autocorrelation function in the Zetasizer
system. The number distribution of the particles in the
medium was obtained through conversion of the
volume distribution (Malvern Instruments 2004). Prior
to measurement, samples were dispersed (at 100 lg/mL)
in water and in DMEM (DMEM High Glucose,
w/L-Glutamine, Gibco, USA) supplemented with 0,
5, or 10 % fetal bovine serum (FBS; Gibco, USA).
To decrease the agglomeration state, the dispersions
were sonicated in an ice bath using an ultrasonic
probe (7 W, 22 kHz) for 7 min prior to measurement.
Sedimentation study
The sedimentation rates of the particles were analyzed
by monitoring the optical absorbance (at 367 and
378 nm for the nano- and micro-sized ZnO, respec-
tively) as a function of time, within 24 h, using UV–
Vis spectrophotometry (Varian 50 Bio, CA, USA).
The dispersion guide for all suspensions was the same
as that for the hydrodynamic size measurements
described above.
Analysis of zinc ions in medium
The levels of Zn2? release in the serum-containing
and serum-free media were compared for the nano-
and micro-ZnO. Particles from a stock suspension
(2 mg/mL) were diluted to 40, 20, and 10 lg/mL with
serum-free DMEM and DMEM/10 % FBS, then
incubated for 24 h at 37 C. Aliquots (1 mL) were
then centrifuged (15,0009g, 25 min) and diluted (1:40,
v/v) with water. The resulting zinc solutions were
analyzed using inductively coupled plasma mass spec-
trometry (ICP-MS, Perkin-Elmer SCIEX ELAN 5000).
The Zn2? ion concentration was determined from
the intensity of the Zn isotope having a mass-to-charge
(m/z) ratio of 66; an external standard curve was used.
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Cell culture
The human lung carcinoma epithelial cell line A549
(BCRC-60074, Hsin-Chu, Taiwan) was cultured in
DMEM supplemented with 10 % FBS and 1 %
Antibiotic–Antimycotic and then cultivated in T25
flasks at 37 C in a humidified atmosphere of 5 %
CO2/95 % air.
Sample preparation
To prepare the stock solution, ZnO powders were
suspended in sterile water at a concentration of
2 mg/mL. Prior to the next step of dilution, they were
dispersed using a 5-W probe sonicator (Ultrasonic Cell
Disruptor, Misonix, USA) for 1.5 min in an ice bath.
Stock solutions were then diluted to concentrations
ranging from 80 to 5 lg/mL in DMEM supplemented
with 0, 5, or 10 % FBS. All diluted suspensions were
then sonicated using a sonicator bath for 10 min at
400 W to break up the agglomerates. Finally, the cells
were treated with these suspensions. In order to
evaluate the effect of Zn2? release from ZnO particles
on cytotoxicity, the supernatants of ZnO particles from
10, 20, and 40 lg/mL of ZnO suspensions were used
to treat cells (in DMEM supplemented with 0 or 10 %
FBS). After preparing the ZnO suspensions, they were
incubated for 24 h at 37 C and centrifuged at
15,0009g for 25 min. The supernatants then could
be obtained. For assessment of the cytotoxicity, the
cells (4 9 104 cells/mL) were seeded in 96-well
plates and then exposed to ZnO suspensions or
supernatants for 24 h after 24 h of cell attachment.
Cell morphology
Cell morphology was assessed using an inverted
optical microscope (Zoomkop EZ-20I, Leader Scien-
tific) coupled to a digital compact camera system (SP-
350, Olympus).
Mitochondria activity
After exposure, the cell medium was aspired and the
aliquots were transferred to a clean flat-bottomed
plate for subsequent IL-8 analysis. Cells were washed
once with 19 phosphate-buffered saline to remove
residual NPs. Next, 200 lL of a 3-(4,5-dimethylthi-
azol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)/
DMEM (with 10 % FBS) solution (0.5 mg/mL) was
added to each well; the plate was then incubated for
3 h. After incubation, the MTT solution was dis-
carded and DMSO (200 lL) was added. Finally,
the absorbance was measured at 570 nm using a
tunable microplate reader (VersaMax, Molecular
Devices, USA). The MTT activity (%) was calculated
using the expression cell number of testing samples½ =
cell number of control½   100:
Production of pro-inflammatory factor
A human IL-8 enzyme-linked immunosorbent assay
(Human IL-8 ELISA Kit and Buffer, PeproTech,
USA) was used to evaluate the production of the pro-
inflammation chemokine IL-8. After a 24 h treatment,
supernatants in each well were collected and analyzed
according to the manufacturer’s protocol.
Statistics
One-way analyses of variance (ANOVA) followed by
Dunnett’s multiple comparison tests and two-tailed
Student’s t test were used, respectively, to evaluate for
the significance between control and each of the other
samples, as well as to compare cytotoxic differences
between nano- and micro-sized ZnO. A subsequent
two-way ANOVA was applied to determine for the
respective effects after adjustment for serum and
particle size categories. Linear regression analysis was
used to evaluate the correlation level among the
cytotoxicity and inflammation responses.
Results
Characterization of ZnO particles
Figure 1 presents TEM images of the nano- and
micro-sized ZnO. Both commercial nanopowders
aggregated slightly in ethanol, and their morphologies
were non-uniform. The primary size corresponded to
our expectation (nano-size ZnO: 50–70 nm; micro-
size ZnO: \1 lm). To assess the differences in size
distributions between the powder forms and medium
suspensions, we measured the size distributions for
nano- and micro ZnO in air and in aqueous medium
(Fig. 2). From the ELPI real-time monitoring data, the
size distribution of the ZnO NPs, based on the
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aerodynamic diameter, was 55–280 nm, although
almost all of the particles had a diameter of approx-
imately 100 nm. The size distribution of micro-sized
ZnO mainly ranged from 55 to 1,000 nm, with only a
small portion being described as having nanoscale
dimensions. The specific surface area (SSA) of nano-
and micro ZnO was 7.34 and 1.81 m2/g, respectively.
When ZnO NPs were dispersed in de-ionized water,
they aggregated slightly to 279 nm (Table 1); in
contrast, the aggregation of the micro-ZnO was less
serious (530 nm). When the nano- and micro-sized
ZnO particles were suspended in serum-free DMEM,
their sizes increased to 936 and 1,107 nm, respec-
tively. The agglomeration of nano- and micro-sized
ZnO decreased when FBS was present in the cell
culture medium. The aggregate sizes of the nano-ZnO
in DMEM containing 5 and 10 % FBS were 320 and
329 nm, respectively; those of the micro-sized ZnO in
DMEM containing 5 and 10 % FBS were 554 and
634 nm, respectively. Nevertheless, neither DMEM/
5 % FBS nor DMEM/10 % FBS caused the size
distribution of the ZnO particles to come close to their
aerodynamic sizes. In addition to the mean size
information, cumulant analysis also provided a poly-
dispersity index (PDI), a width parameter. From the
zeta potential analysis (Table 1), the two kinds of ZnO
particles both featured positive surface charge in de-
ionized water (22–26 mV); after suspension in
DMEM medium, the zeta potentials turned negative
(-2.4 and -4.0 mV for nano- and micro-ZnO,
respectively) and became close to the zero-point of
charge (ZPC). The zeta potentials of the ZnO particles
decreased slightly, reaching between -7 and
-10 mV, in DMEM/5 % FBS and DMEM/10 % FBS.
Sedimentation study
Figure 3 displays the sedimentation state of the nano-
and micro-sized ZnO in the various media. Particles in
serum-free DMEM exhibited a faster sedimentation
rate than those in the serum-containing media. Almost
all of the particles (both nano- and micro-ZnO)
Fig. 1 TEM images of ZnO particles. a nano-ZnO. b micro-
ZnO
Fig. 2 Size distributions of ZnO particles suspended in air,
water, and DMEM with various percentages of FBS (dp
aerodynamic diameter; dH hydrodynamic diameter)
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precipitated within 24 h; that is, they were very
unstable in serum-free media. In contrast, the sedi-
mentation rates were slower when FBS was present.
The same particles had similar stabilities in the various
FBS-containing media. Nevertheless, the micro-sized
ZnO underwent faster sedimentation than did the
nano-sized ZnO in both FBS-containing media.
Cell morphology
The morphologies of the A549 cells grown without
serum and with 5 or 10 % serum (control group) in the
DMEM medium were not significantly different after
24 h (Fig. 4a–c). There was, however, the highest
confluence and density of cells cultured in the medium
incorporating 10 % FBS. When the A549 cells were
treated with 20 lg/mL of nano-ZnO in serum-free
medium, almost all of the cells retracted into a
partially smaller spherical shape and exhibited
decreased confluence from those in control (Fig. 4d);
a smaller portion of the cells exhibited the same
changes in morphology at the same concentration of
the suspensions in the serum-containing medium
(Fig. 4e, f). In the 20 lg/mL of micro-ZnO treated
group, some cells with normal morphologies could be
observed in serum-free medium (Fig. 4g). A small
portion of cells exhibited abnormal changes in mor-
phology at the same concentration of the suspensions
in the serum-containing medium (Fig. 4h, i).
Cell viability of ZnO particles
Figure 5 presents A549 cell viability of the nano- and
micro-ZnO in DMEM supplemented with 0, 5, and
10 % FBS. The average optical densities of the MTT
formazan in the 0, 5, and 10 % FBS/DMEM control
groups were 1.4, 2.5, and 2.8, respectively, revealing
that the rate of cell growth was proportional to the
amount of serum added. Dose-dependent declines in
viability occurred in each kind of medium. Two-way
ANOVA revealed significant differences in toxicity
for samples treated in three different medium condi-
tions after adjustment for particle size (p \ 0.001 at
10–80 lg/mL). The toxicities for both sizes of ZnO
particles in the different media decreased in the
following order: in serum-free DMEM [ in DMEM/
5 % FBS [ DMEM/10 % FBS. Furthermore, in all
medium conditions, significant differences in cyto-
toxicity were found when comparing nano-ZnO and
micro-ZnO samples by Student’s t test (p \ 0.05 at
20–80 lg/mL). The results indicated that regardless of
the conditions, the nano-sized ZnO was more toxic
than the micro-sized ZnO at concentrations of
20–80 lg/mL. However, the size-dependent effect
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Fig. 3 Sedimentation curves of ZnO particles (100 lg/mL) for
various percentages of FBS in DMEM, y-axis expressed in terms
of absorbance at time t (At) relative to that at t = 0 (A0)
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could not be observed at concentrations of 5 and
10 lg/mL.
Mass concentration dosages in Fig. 5 were con-
verted to SSA-based dosages in Fig. 6. In the same
SSA, micro-ZnO was more toxic than nano-ZnO in
both serum-containing media (Fig. 6). At
1.4 9 10-4 m2/mL of dosage, the differences of cell
viability between nano- and micro-ZnO in serum-free
media became smaller than in serum-containing
media. Moreover, the cell viability showed a single
tendency of dose-dependence decline within both two
materials in serum-free media.
Release of zinc ions in media and its cytotoxicity
To assess the extent of Zn2? released in the serum-
containing and serum-free media, we evaluated the
effects of the two ZnO particles at different concen-
trations (Fig. 7a). In the same medium and at the same
concentration, we observed no significant differences
in the release of Zn2? between the two sizes of ZnO
particles. Nevertheless, 40 lg/mL of nano-ZnO in
DMEM/10 % FBS released 15.9 lg/mL of Zn2?
within 24 h, more than that in the serum-free medium
(8.7 lg/mL). We observed a similar level in Zn2?
release in two different media for nano-ZnO at 10 lg/mL
(8.3 lg/mL in DMEM/10 % FBS; 8.1 lg/mL in serum-
free DMEM). On the other hand, the increase of Zn2?
could be seen as the concentration of the ZnO suspension
increasing from 10 to 40 lg/mL in DMEM/10 % FBS,
while there was a similar level of zinc ion release
in serum-free medium. The morphologies of nano-ZnO
in DMEM or DMEM/10 % FBS media are given in
Supplementary Information.
To determine the Zn2? release contributing to the
cytotoxicity of ZnO particles in various media, we
analyzed the cytotoxicity induced by supernatants of
ZnO particle suspensions. As shown in Fig. 7b, there
are no cytotoxicity differences between nano-ZnO and
micro-ZnO-derived supernatants, both in serum-free
and DMEM/10 % FBS. When the supernatants were
derived from serum-free media, significant
Fig. 4 Morphologies of
A549 cells exposed to
20 lg/mL of nano- and
micro-ZnO for 24 h in
DMEM with various
percentages of FBS.
a–c Cell control groups.
d–f Cells treated with nano-
ZnO. g–i Cells treated with
micro-ZnO. The scale bar is
100 lm
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cytotoxicity could be observed markedly. However,
when the supernatants were composed of DMEM/
10 % FBS, there were no cytotoxicity for 10–40 lg/mL
of ZnO supernatants.
Pro-inflammatory factor responses and relation
between cellular effects
Figure 8a shows the IL-8 release from A549 cells after
treatment for 24 h with the different ZnO samples and
exposure conditions. The production of IL-8 showed
significant differences between control groups (32, 49,
and 61 pg/mL after exposure in DMEM, DMEM/5 %
FBS, and DMEM/10 % FBS, respectively) (Fig. 8a).
In the absence of serum, both nano- and micro-ZnO
induced the greatest IL-8 expression at 20 lg/mL and
then the expression decreased. Statistical analysis only
shows significant differences in IL-8 production
between nano- and micro-ZnO at 20 and 40 lg/mL,
and shows significant differences between control and
treated groups for nearly all dosages. In the presence
of serum, the IL-8 expression in all treated groups was
higher than in serum-free media. From one-way
ANOVA analysis, significant IL-8 release from
A549 cells treated with samples as compared to the
control group can be observed ([20 lg/mL). How-
ever, inconsistent with the cell viability results, none
of the groups had a significant effect on IL-8
production between nano- and micro-ZnO. Two factor
ANOVA analyses revealed significant contrasts only
related to serum conditions for all dosages after
adjustment for particle size (p \ 0.01), while no
significant contrasts related to particle size after
adjustment for serum conditions.
To determine the association between cytotoxicity
and inflammation responses as measured by MTT and
IL-8 ELISA assay, linear correlation analyses were
Fig. 5 MTT activities of
A549 cells after 24 h
exposure to nano- and
micro-ZnO in DMEM with
various percentages of FBS.
*p \ 0.05 compared to
untreated controls;
dp \ 0.05 compared
between treated groups.
Particle size and serum-
related contrasts were both
observed by two-way
ANOVA, p \ 0.001 at
20–80 lg/mL
Fig. 6 MTT activities of A549 cells after 24 h exposure to 20,
40, and 80 lg/mL of nano- and micro-ZnO using particle SSA
as dosimetry
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performed. Results are shown in Fig. 9. All samples
within the same exposure condition were considered
together, thus each condition had 8 units of data to
make a correlation analysis. Significant inverse cor-
relations were found between cell viability and
production of IL-8 when A549 cells were treated in
Fig. 7 Dissolution of ZnO
particles in cell medium and
cytotoxicity for dissolved
zinc. a Zn2? released from
nano- and micro-ZnO in
serum-free DMEM and
DMEM/10 % FBS after
24 h and 37 C incubation.
b MTT activities of A549
cells after 24 h exposure to
supernatant of ZnO particles
suspensions. *p \ 0.05
compared to untreated
controls
Fig. 8 IL-8 production
from A549 cells after 24 h
exposure to nano- and
micro-ZnO in DMEM with
various percentages of FBS.
a y-axis is expressed as
production of IL-8 (pg/mL).
b y-axis is expressed as IL-8
releasing folder (% of
control). *p \ 0.05
compared to untreated




contrasts related to serum
factor for all dosages, upon
adjustment of particle size,
p \ 0.01
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serum-containing media (in 5 % FBS, r = -0.78; in
10 % FBS, r = -0.77), whereas no correlation was
observed as cells were treated in serum-free media
(r = -0.04).
Discussion
According to a predictive mathematical model from
the International Commission on Radiological Pro-
tection (ICRP), particles having dimensions between
0.005 and 1 lm can deposit in the alveolar region of
the human respiratory tract under nasal breathing
conditions during rest (Bair 1994). In this study, the
nano-ZnO particles that we tested had dimensions
(theoretically) of less than 100 nm, although moni-
tored data indicated that some NPs aggregated slightly
to dimensions of less than 280 nm, due to the higher
relative humidity in air (Abouzeid and Fuersten 1972).
The size distribution of the micro-ZnO particles in air
was also less than 1 lm. Therefore, both sets of
particles that we used have the potential to deposit and
have hazardous effects on alveolar epithelial cells.
Before the particles come into contact with the cells,
they would have to penetrate a surfactant-containing
liquid layer (Kreyling and Geiser 2010). Such passage
through this layer might lead to particle agglomera-
tion, but the extent of agglomeration would depend on
the surface charge of the particles and the presence of
dispersants and adsorbed protein (Holgate 2010).
Furthermore, the agglomeration of particles would
also determine the cell uptake pathway (phagocytosis
or pinocytosis) and the cytotoxicity (Casals et al.
2008). Therefore, to determine which medium com-
ponents are most appropriate for evaluating NP
cytotoxicity, it is important to calculate their size
distributions in various media. When we dispersed our
nano- and micro-ZnO particles in serum-free DMEM,
they aggregated dramatically, presumably because of
the high concentration of ionic salts in the medium
(zeta potential close to zero) and also the presence of
low amounts of amino acids, vitamins, and glucose
(Allouni et al. 2009). We also observed decreases in
the hydrodynamic sizes and zeta potentials after the
addition of serum (at either 5 or 10 % in DMEM),
presumably because of protein adsorption on the
surfaces of particles (Allouni et al. 2009).
In addition to particle agglomeration, the rate of
particle sedimentation is also relevant when evaluat-
ing the potential cytotoxicity of NPs (Limbach et al.
2005). The faster the particles deposit, the more likely
they are to interact with the cells. In the serum-
containing media, both the nano- and micro-ZnO
formed more stable suspensions than they did in the
serum-free medium, presumably because the albu-
min—the main component of serum protein—has a
net negative charge in DMEM, allowing it to bind to
positively charged ZnO through its carboxyl groups
(RCOO-). The adsorption of these proteins on the
surface of ZnO also induced steric stabilization.
Micro-sized ZnO underwent faster sedimentation than
did the nano-sized ZnO in all of the tested solutions,
presumably because the weight of micro-ZnO aggre-
gates was greater than that of the nano-ZnO aggre-
gates. Recent research has made strides toward
developing new technologies in NP dispersion for
in vivo and in vitro studies (Bihari et al. 2008; Vippola
et al. 2009). For example, the addition of dipalmitoyl-
phosphatidylcholine (DPPC), the major component of
lung surfactant, to serum-containing media provided a
more stable, less-agglomerating suspension of TiO2
and carbon-based NPs (Vippola et al. 2009). In
addition, the presence of DPPC also can modulate
the oxidative stress response of human lung epithelial
cells upon exposure to carbon nanomaterials (Herzog
et al. 2009). To date, however, the most common
dispersion agent used for in vitro studies has been
either FBS or bovine serum albumin (Ji et al. 2010).
The degree of metal ion release is another important
toxicity resource. For example, Zn2? is a toxic ion
Fig. 9 Correlations between mitochondrial activities (MTT)
and inflammatory (IL-8) results of samples in A549 cells with
various medium conditions. r correlation coefficients
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because it can inhibit mitochondrial respiration,
leading to loss of intracellular adenosine triphosphate
(Marin et al. 2000; Daniels et al. 2004). Xia et al.
reported that the maximum total Zn2? release from
nano-ZnO in complete DMEM (DMEM/10 % FBS)
was 225 lM (Xia et al. 2008). Deng et al. claimed that
when less than 18.2 lg/mL of ZnO NPs was present,
the cells were mainly exposed to aqueous Zn2? (Deng
et al. 2009). Song et al. used supernatants of ZnO
particle suspension to treat mouse macrophage cells,
and found significant correlations between Zn2?
concentration and cell viability results (Song et al.
2010). However, Park et al. evaluated negligible Zn2?
concentration from nano-ZnO in both neutral (PBS,
pH 7.4) and acidic solvent (HCl, pH 4.5–5.0), and
considered zinc ion release was not a critical factor in
ZnO toxicity (Park et al. 2011). Ahamed et al. found
that ZnO nano-rods released less than 10 lg/mL of
Zn2? at a particle concentration lower than 100 lg/mL,
and that these levels of Zn2? release were insufficient to
induce cytotoxicity of A549 cells (Ahamed et al. 2011).
In this study, we first observed similar degrees of Zn2?
release from both the nano- and micro-sized ZnO which
was consistent with the results reported by Song et al.
(2010). We also found that when dissolving 10 lg/mL
of nano- and micro-ZnO in all conditions of media,
around 8 lg/mL of Zn2? was detected. By combining
the bio-TEM observation (Supplementary Informa-
tion), these results indicated that almost all ZnO
particles were dissolved into zinc ion at this concen-
tration. Our cytotoxicity results under this dosage had
no significant differences compared with the control
group in DMEM/10 % FBS media, while having
significant differences in cytotoxicity between them in
serum-free media. We examined the toxic effect of
dissolved Zn2? supernatants from 10 lg/mL of nano-
ZnO and micro-ZnO in A549 cells and found that Zn2?
caused no apparent cytotoxicity in DMEM/10 % FBS
media, while there was a slight decrease in cell viability
under serum-free media, consistent with the cytotoxic-
ity results of ZnO particles. Furthermore, we observed
higher degrees of Zn2? release in serum-containing
media than serum-free media by dissolving 40 lg/mL
of nano- and micro-ZnO. The cytotoxicity study for the
supernatants received from 40 to 10 lg/mL of ZnO
particles showed similar cytotoxicity in serum-free
media, while still no apparent cytotoxicity was found
from the supernatants in DMEM/10 % FBS media.
These results suggest that dissolved Zn2? in serum-free
media made a greater impact on toxic responses of ZnO
particles than that dissolved in serum-containing media,
and some complex between the FBS protein and zinc
ion occurred in serum-containing media. On the other
hand, we found that ZnO in serum-containing media
releases relatively more zinc ion than in serum-free
media. The possible reason for the different levels of
ZnO dissolution in water, serum-free and serum-
containing media is discussed in Supplementary
Information.
Cell growth is another important factor affected by
the toxicity of NPs. We observed slower growth rate of
A549 cells exposed to the serum-free medium, due to
the absence of growth nutrients and factors. Even if
there were an equal cell density prior to the exposure
step, cells undergoing a slower growth rate would lead
to a lower cell density. Heng et al. demonstrated that a
sparse monolayer cell density was less resistant to the
cytotoxicity of nano-ZnO compared to a higher cell
density for four different cell lines (Heng et al. 2011).
A higher relative dosage of particles to cells, attributed
to lower cell density, might induce a more serious
cytotoxicity. Furthermore, the starved cells were
incubated in a nutrient-absent medium, which might
trend more toward the uptake of ZnO particles; but
severe particle aggregation in a serum-free medium
might vary the uptake mechanism and lower the
uptake. Thus, the uptake level of ZnO particles in time
and space resolved should be further studied. The
strategy developed by Shapero et al. could be utilized
(Shapero et al. 2011).
The effect of protein adsorption on the cytotoxicity
of NPs has been noted in several reports (Horie et al.
2009; Ge et al. 2011; Hu et al. 2011). For example, the
presence of serum in a medium can have a protective
effect on the toxicity of single-walled carbon nano-
tubes and graphene oxide (Ge et al. 2011; Hu et al.
2011). One report concluded that nano-ZnO requires
cell contact to exhibit its cytotoxicity (Moos et al.
2010). Based on the bio-TEM results, the production
of nano-bio-complex in DMEM/10 % FBS might
cause less cell–particle contact, thereby decreasing the
cytotoxicity. In addition, we should not neglect
considering possible different components of protein
corona in the absence or presence of serum effects on
particle–cell interaction (Cedervall et al. 2007; Lynch
and Dawson 2008; Lynch et al. 2009; Nel et al. 2009;
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Walkey and Chan 2012), and possible protein confor-
mation change/aggregation induced by NPs that
destroy protein activity (Prapainop et al. 2012; Walkey
and Chan 2012).
We observed size-dependent toxicity of nano- and
micro-ZnO in both media, with and without serum at
dosages C 20 lg/mL. Similar results have been
reported previously. Moos et al. noted that nano-sized
ZnO was more toxic than micrometer-sized ZnO
toward human colon cancer cells (RKO) (Moos et al.
2010). Nair et al. revealed that the toxicity of ZnO NPs
was greater than that of ZnO microparticles toward
human osteoblast cancer cells (MG-63) (Nair et al.
2009). Furthermore, Hanley et al. also reported
significantly greater cytotoxicity of 4-nm ZnO NPs
relative to 20-nm ZnO NPs (Hanley et al. 2009). In
contrast, Deng et al. found no size-dependent toxicity
of 10-, 30-, 60-, and 200-nm ZnO NPs for mouse
neural stem cells (Deng et al. 2009). Yuan et al.
reported that the cytotoxicity was independent of the
size of nano-ZnO (20, 30, and 40 nm) to human
embryonic lung fibroblasts (Yuan et al. 2010). The
reason for an absence of a size-dependent effect might
be the dissolution of Zn2? (Deng et al. 2009), or the
size of ZnO did not exceed a certain critical size (Song
et al. 2010). In this present study, we inferred that for
concentrations of ZnO in the media B10 lg/mL, there
was no size-dependent toxicity due to all particles
being dissolved into Zn2?. When the dosage of ZnO
particles was C 20 lg/mL, the degree of Zn2? release
increased in serum-containing media. We also noted a
similar degree of Zn2? release from the nano- and
micro-ZnO under otherwise identical conditions. In
addition, Zn2? release from ZnO particles exhibited
toxic response to cells only in serum-free media
(10–40 lg/mL of ZnO supernatants). These results
suggest that although the presence of Zn2? in serum-
containing or serum-free media did not affect, or
slightly affected, the cytotoxicity of ZnO, the non-
dissolved remnants of the NPs play a major role in
influencing their cytotoxicity. In our previous study,
we found that smaller-sized nano-ZnO (of both rod
and spherical shapes), with a smaller primary size,
formed a relatively smaller secondary size in serum-
free medium, thereby resulting in more cytotoxicity
relative to larger-sized nano-ZnO (Hsiao and Huang
2011a). In this present study, we confirmed ZnO
particles having a smaller primary size aggregated to a
relatively smaller secondary size in all of the tested
media. In the same mass dosage, larger particle
numbers and surface areas for smaller particle sizes
resulted in size-dependent cytotoxicity. It also con-
cluded that mass dosimetry is appropriate to compare
the toxicity between these two size of material due to
there were totally different components of zinc at
various dosages. However, if ZnO dissolves very
quickly, e.g., B10 lg/mL, then dissolution rate dom-
inates over size dependency and no cytotoxicity
differences were observed. Though the Zn2? ions
within the extracellular environment contributed little
to cytotoxicity of higher concentrations of ZnO
particulates, it did not mean that possible intracellular
Zn2?, which dissolved in acidic conditions within the
lysosomal and alveolar compartments of cells after
ZnO particle uptake, would also show little effect,
because the mechanisms are totally different.
The opposite dose-dependent effect on the two
sizes of ZnO could be observed between mass-based
and SSA-based dosimetries. The results correspond to
the Lin’s research (Lin et al. 2009). Our data further
revealed that there was no correlation between particle
surface area and cytotoxicity as in serum-containing
media, while in serum-free exposure the surface area
dependent toxicity could be observed. Many reasons
include increase of ZnO dissolution, lower sedimen-
tation rate and serum-coated particles in serum-
containing media all may explain our results. They
all decrease the toxic contribution from the surface of
particles. These findings suggested that it’s inappro-
priate to use surface area dosimetry in studying the
cytotoxicity of ZnO in serum-containing media
because the ‘‘real’’ surface area of the particles
contacting the cells determines the toxicity (Hsiao
and Huang 2011a).
Cronholm et al. found less particle agglomeration
and increased Cu release in serum-containing medium
(Cronholm et al. 2011), while having no clear
difference in toxicity to A549 cells. This study tried
to figure out and discuss which factors might affect the
toxicity difference between serum and serum-free
media. The possible factors to be considered include
physicochemical properties and cellular behaviors.
Table 2 summarizes possible influencing factors that
contributed to the cytotoxicity of nano-ZnO in various
media. For the NPs in the serum-free medium, large
aggregates of particles lead to rapid sedimentation.
Thus, larger parts of particles have more opportunities
to directly contact with cells in the absence of protein
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protection. Collaborating with a low cell-growth rate,
these factors contribute to high dosage-per-cell ratio.
Though less Zn2? release was observed in the serum-
free medium, it was more potentially toxic than that in
serum-containing media. On the other hand, the
physicochemical properties of nano-ZnO were similar
both in 5 and 10 % FBS-containing media, while
cytotoxicity differences still existed. This indicated
that cell growth rate dominated this difference within
the serum-containing media.
IL-8 is an important chemokine to mediate
pulmonary inflammation, and also a good marker to
evaluate an intermediate level (Tier 2) of oxidative
stress on in vitro and in vivo studies (Nel et al. 2006).
In vitro studies have also demonstrated that NPs can
up-regulate IL-8 in human lung epithelial cells. Baktur
et al. demonstrated that IL-8 expression is enhanced in
the presence of serum when carbon nanotubes
(SWCNTs) were exposed to A549 cells even if a
lower cytotoxicity was observed (Baktur et al. 2011).
This is because more SWCNTs penetrated into cells in
the presence of serum. Our study also found the same
IL-8 results for both ZnO particles. Both the uptake
mechanism and level might affect the expression, but
more biological information was required to explain.
Interestingly, the IL-8 expression in three control
groups showed high correlation with its corresponding
OD values of MTT assay (r = 0.95). This suggested
that more cell numbers for both control and treated
groups in serum-containing medium contributed to a
higher expression. Actually, if we changed the y-axis
expression [production of IL-8 (pg/mL)] in Fig. 8b to
a percentage of IL-8 release to control (%) as a
substitute to compare the releasing folder between
each case, nano-ZnO in the serum-free medium even
induced the highest fold (approximately 2.8 times) for
the IL-8 at 20 lg/mL than that in the serum-containing
medium at all dosages. In addition, size-dependent
inflammation response was observed only in groups of
serum-free media. These results suggested that cells
were more sensitive to xenobiotics in a nutrient-
deficient state. On the other hand, it showed high
association between cell viability and IL-8 expression
data in serum-containing media, which is consistent
with some previous studies (De Berardis et al. 2010;
Perrone et al. 2010). However, the correlation was not
found in serum-free media, implying that some
signaling pathways might alter under this condition.
In general, in vitro studies are performed using
serum-free media to avoid complicated particle–
protein interactions as, for example, shown by Casey
et al. who demonstrated that FBS interacts with carbon
nanotubes (Casey et al. 2007), or in other cases to
avoid interference in biological assays [e.g., from
lactate dehydrogenase (Hollaar and Vanderlaarse
1979)]. In our present study, however, serious
agglomeration of the NPs in the serum-free medium
may have led to loss of their original surface properties
and rapid particle–cell interaction. Furthermore, in the
absence of nutrients and proteins, cultures might
experience increased cell stress, increased phagocy-
tosis (Walker et al. 1991), and altered transcription
behavior for protein production (Jones and Grainger
2009). Although we did not observe a cytokine
adsorption effect for ZnO NPs in our previous studies,
this effect does occur with negatively charged NPs
[e.g., TiO2 (Hsiao and Huang 2011b)]. These impli-
cations might lead to errors in determining ‘‘real
world’’ toxicity. After all, no in vivo system features
an absence of serum protein. In the absence of any
special reasons, we recommend the use of a serum-
containing medium when evaluating the cytotoxicity
of NPs. Finally, in selecting stabilizing agents for
in vitro testing, it is important to consider not only
from biological aspects (e.g., bioavailability and real
situation of exposure), but also from NPs aspects (e.g.,
additional dissolution and surface charge alternation).
Conclusion
In this study, we have demonstrated that the degrees of
ZnO cytotoxicity are different when the particles are
exposed to either serum-containing or serum-free
media. In serum-free media, higher ZnO toxicity








Secondary size Large Small Small
Sedimentation rate Fast Slow Slow
Zinc ion release Low – High
Protein protection No Yes Yes
Cell growth rate Slow Medium Fast
Resultant toxicity High Medium Low
J Nanopart Res (2013) 15:1829 Page 13 of 16
123
ensues, not only because of large aggregates of
particles, rapid sedimentation of suspension, larger
parts of particles directly contacting with cells in
absence of protein protection, and a lower cell growth
rate, all contributing to high dosage-per-cell ratio, but
also because Zn2? release from ZnO particles con-
tribute to cytotoxicity. In serum-containing media,
even though two kinds of ZnO featured a smaller
particle size than that in serum-free media, the faster
cell growth rate, formation of a stable suspension,
lower cytotoxicity response to Zn2?, and serum
protection all led to lower cytotoxicity. Moreover,
we also demonstrated that no matter which medium,
extracellular Zn2? release did not contribute as a main
factor in cytotoxicity of nano-ZnO, suggesting that the
non-dissolved remnants of the ZnO particles must
contribute to their cytotoxicity; thereby explaining the
observed size-dependent toxicity at higher exposure
concentration. Finally, since growth rate, transcription
behavior of cells, and physicochemical properties of
ZnO particles all might be altered in a serum-free
exposure condition, the addition of FBS to the media
might appear to be appropriate when assessing the
cytotoxicity of NPs.
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